DUPHAT 2026 Spotlights Pharma 4.0, Digital Transformation, Emerging Research Talent
Faizan Hashmi
Published August 26, 2026 | 08:30 PM
DUBAI, (UrduPoint / Pakistan Point News / WAM – 26th Aug, 2026) The 31st Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT 2026) continued its second day, under the theme "Reformulating the Future of Pharma", focusing on digital transformation, Pharma 4.0™, and the development of emerging pharmaceutical talent.
The program featured specialized sessions on:
- the future of pharmaceutical manufacturing
- the role of digital technologies and automation in improving production efficiency while ensuring quality, safety, and regulatory compliance
Key Discussions:
- The International Society for Pharmaceutical Engineering (ISPE), in collaboration with the Emirates Drug Establishment (EDE), supporting Pharma 4.0™ concepts in the UAE.
- Transitioning pharmaceutical companies to smarter, more flexible manufacturing models through gradual digital transformation, automation, and assessment of organizational readiness and digital maturity.
- Pharmaceutical quality management systems aligned with ICH Q10 principles
- Utilizing digital tools across the product lifecycle, from research and development to manufacturing, quality control, and market launch.
Speakers emphasized:
- The importance of selecting appropriate technologies for each stage of production to support secure, progressive, and regulatory-compliant digital transformation.
DUPHAT 2026 also showcased:
- DUPHAT Research Global Award 2026: Recognizing early-career researchers and providing a platform for them to present their research to experts and professionals.
- DUPHAT 2026 Pharmacy Students Competition: Offering students an opportunity to demonstrate their scientific knowledge, engage with specialists, and develop skills in research, innovation, and critical thinking.
Additionally, MetroMed and MEAgate announced an expansion of their seven-year partnership, with MEAgate adding a new range of ophthalmology products to its portfolio distributed by MetroMed. This announcement highlighted DUPHAT’s role as a platform for:
- Strengthening partnerships
- Expanding product portfolios
- Exploring regional growth opportunities.
DUPHAT 2026 is officially supported by the Emirates Drug Establishment and Dubai Health Authority and organized by INDEX Conferences and Exhibitions Org., a member of INDEX Holding, with support from several international pharmaceutical and pharmacy organizations.
